CVS Health grew its revenues by 2.6% in the second quarter, crediting this year-over-year improvement in part to its growing number of digital customers, its...
CVS Health has launched Cordavis, a new subsidiary focused on bringing high-quality biosimilar products to the market to reduce drug costs. Biosimilars are FDA-approved biologic medications...